Sean Parker
commented on
$Maxeon Solar Technologies (MAXN.US)$
1. Skyrocketing Cost-to-Borrow (CTB) Rates:
• The average CTB rate is 237.95%, and it peaks at 305.5%. These extremely high borrowing costs are unsustainable for shorts, pressuring them to cover their positions quickly.
2. Short Availability Drying Up:
• On multiple occasions, the short share availability has been 0 (e.g., October 23, 13:45), signaling an extreme scarcity of shares to borrow. This shortage is likely to further...
1. Skyrocketing Cost-to-Borrow (CTB) Rates:
• The average CTB rate is 237.95%, and it peaks at 305.5%. These extremely high borrowing costs are unsustainable for shorts, pressuring them to cover their positions quickly.
2. Short Availability Drying Up:
• On multiple occasions, the short share availability has been 0 (e.g., October 23, 13:45), signaling an extreme scarcity of shares to borrow. This shortage is likely to further...
8
5
Sean Parker
reacted to and commented on
$Tevogen Bio Holdings (TVGN.US)$ that is it Sell this dead meat
1
4
Sean Parker
liked and commented on
$Archer Aviation (ACHR.US)$
Archer Applauds FAA's Final Rules for Operating eVTOL Aircraft2 HOURS AGO, 6:30 AM CDTVIA BUSINESSWIREACHRSHARE
Archer Aviation Inc. (NYSE:ACHR) today provided commentary on the much anticipated FAA release of the final powered-lift Special Federal Aviation Regulation (SFAR) which is the key operational piece of the regulatory puzzle for Archer and the rest of the industry to be able to firm up their plans for safely commercializing eVTOL in the U.S. T...
Archer Applauds FAA's Final Rules for Operating eVTOL Aircraft2 HOURS AGO, 6:30 AM CDTVIA BUSINESSWIREACHRSHARE
Archer Aviation Inc. (NYSE:ACHR) today provided commentary on the much anticipated FAA release of the final powered-lift Special Federal Aviation Regulation (SFAR) which is the key operational piece of the regulatory puzzle for Archer and the rest of the industry to be able to firm up their plans for safely commercializing eVTOL in the U.S. T...
5
Sean Parker
liked
$BranchOut Food (BOF.US)$ Reuters· 2 mins ago
BranchOut Food Shareholder Update: Projects $15M Run Rate and Positive Cash Flow for Q1 2025 Amid Surge in New Orders as Peru Factory Opens
BranchOut Food Shareholder Update: Projects $15M Run Rate and Positive Cash Flow for Q1 2025 Amid Surge in New Orders as Peru Factory Opens
3
$Passage Bio (PASG.US)$
PHILADELPHIA, October 24, 2024 — Passage Bio, Inc. (Nasdaq: PASG), a clinical stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases, today announced the company delivered preclinical and interim clinical data as part of an oral presentation at the European Society of Gene & Cell Therapy (ESGCT) 31st Annual Congress being held October 22-25, 2024, in Rome, Italy.
Details of the oral presentation are below:
Abstract Title:...
PHILADELPHIA, October 24, 2024 — Passage Bio, Inc. (Nasdaq: PASG), a clinical stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases, today announced the company delivered preclinical and interim clinical data as part of an oral presentation at the European Society of Gene & Cell Therapy (ESGCT) 31st Annual Congress being held October 22-25, 2024, in Rome, Italy.
Details of the oral presentation are below:
Abstract Title:...
Sean Parker
liked
$Passage Bio (PASG.US)$ Passage Bio Presents Preclinical and Interim Clinical Data for PBFT02 in FTD-GRN at the European Society of Gene & Cell Therapy (ESGCT) 31stAnnual Conference
Preclinical data demonstrated that an AAV1 vector achieved superior human progranulin levels in the CSF as compared to AAV5 and AAVhu68 (an AAV9 variant)
Nonclinical data showed PBFT02 improved lysosomal histopathology and reduced neuroinflammation in Grn knockout mice, and achieved widespread vector distribut...
Preclinical data demonstrated that an AAV1 vector achieved superior human progranulin levels in the CSF as compared to AAV5 and AAVhu68 (an AAV9 variant)
Nonclinical data showed PBFT02 improved lysosomal histopathology and reduced neuroinflammation in Grn knockout mice, and achieved widespread vector distribut...
1
Sean Parker
voted
Hey, mooers!
The Global Paper Trading Challenge has been underway for a week now, and we're thrilled to have over 75,000 participants from around the globe!
In the U.S. region, more than 85 participants have achieved weekly virtual gains exceeding 10%. The most popular stock traded in our Challenge last week? $Bright Minds Biosciences (DRUG.US)$, a pharmaceutical company that just received FDA approval for its new drug. This week, $GRI Bio (GRI.US)$ is curren...
The Global Paper Trading Challenge has been underway for a week now, and we're thrilled to have over 75,000 participants from around the globe!
In the U.S. region, more than 85 participants have achieved weekly virtual gains exceeding 10%. The most popular stock traded in our Challenge last week? $Bright Minds Biosciences (DRUG.US)$, a pharmaceutical company that just received FDA approval for its new drug. This week, $GRI Bio (GRI.US)$ is curren...
+4
17
6